Lmr Partners LLP Dice Therapeutics, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $3.92 Million - $7.09 Million	151,698 New	151,698 $7.05 Million
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $223,726 - $384,982	-15,387 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$22.41 - $37.54 $999,777 - $1.67 Million	-44,613 Reduced 74.36%	15,387 $389,000
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $1.92 Million - $2.22 Million	60,000 New	60,000 $1.97 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.